Provided by Tiger Trade Technology Pte. Ltd.

Cytokinetics

65.62
-0.2900-0.44%
Post-market: 65.620.00000.00%16:20 EDT
Volume:1.72M
Turnover:113.76M
Market Cap:9.12B
PE:-9.14
High:67.27
Open:65.73
Low:65.30
Close:65.91
52wk High:88.31
52wk Low:53.61
Shares:139.02M
Float Shares:138.02M
Volume Ratio:0.76
T/O Rate:1.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.1827
EPS(LYR):-6.5400
ROE:-572.15%
ROA:-28.09%
PB:-52.58
PE(LYR):-10.03

Loading ...

Cytokinetics - Myqorzo Launched in Germany Following European Commission Approval in February 2026

THOMSON REUTERS
·
Jun 01

Cytokinetics Launches Myqorzo® (Aficamten) in European Union, With First Commercial Availability in Germany

THOMSON REUTERS
·
Jun 01

Cytokinetics Launches MYQORZO® (aficamten) in European Union, with First Commercial Availability in Germany

GlobeNewswire
·
Jun 01

Cytokinetics Announces Launch of Myqorzo (Aficamten) in Germany for Symptomatic Obstructive Hypertrophic Cardiomyopathy

THOMSON REUTERS
·
Jun 01

Cytokinetics CEO Makes Major Move With Fresh Stock Sale

TIPRANKS
·
May 29

Cytokinetics CEO Robert I. Blum sells 7,500 shares for $579,075

Reuters
·
May 29

Cytokinetics Shareholders Reinforce Board and Governance Frameworks

TIPRANKS
·
May 28

Cytokinetics shareholders elect three Class I directors at annual meeting

Reuters
·
May 28

Cytokinetics to Participate in June Investor Conferences

GlobeNewswire
·
May 28

Top Cytokinetics Executive Makes Notable Move With Fresh Stock Sale

TIPRANKS
·
May 21

Cytokinetics EVP R&D Malik sells 3,500 shares for $264,915‬

Reuters
·
May 21

Cytokinetics announces annual stockholders meeting

Reuters
·
May 21

Cytokinetics to Hold Annual Meeting of Stockholders

THOMSON REUTERS
·
May 21

How New Aficamten Phase 3 Data and Equity Raise Will Impact Cytokinetics (CYTK) Investors

Simply Wall St.
·
May 19

Cytokinetics Initiated at Buy by Citigroup

Dow Jones
·
May 19

U.S. RESEARCH ROUNDUP-Costco Wholesale, HCA Healthcare, Micron Technology

Reuters
·
May 19

Cytokinetics initiated with a Buy, named a top pick at Citi

TIPRANKS
·
May 19

Cytokinetics grants 20,807 stock options at USD 75.85 under inducement plan

Reuters
·
May 19

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire
·
May 19

Morgan Stanley Sticks to Its Buy Rating for Cytokinetics (CYTK)

TIPRANKS
·
May 18